Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 373

1.

Centralized Reminder/Recall to Increase Influenza Vaccination Rates: A Two-State Pragmatic Randomized Trial.

Kempe A, Saville AW, Albertin C, Helmkamp L, Zhou X, Vangela S, Miriam Dickinson L, Tseng CH, Campbell JD, Whittington M, Gurfinkel D, Roth H, Hoefer D, Szilagyi P.

Acad Pediatr. 2019 Nov 4. pii: S1876-2859(19)30449-8. doi: 10.1016/j.acap.2019.10.015. [Epub ahead of print]

PMID:
31698085
2.

Dysregulated NO/PDE5 signaling in the sickle cell mouse lower urinary tract: Reversal by oral nitrate therapy.

Musicki B, Anele UA, Campbell JD, Karakus S, Shiva S, Silva FH, Burnett AL.

Life Sci. 2019 Oct 18;238:116922. doi: 10.1016/j.lfs.2019.116922. [Epub ahead of print]

PMID:
31634463
3.

Safety profile of autologous macrophage therapy for liver cirrhosis.

Moroni F, Dwyer BJ, Graham C, Pass C, Bailey L, Ritchie L, Mitchell D, Glover A, Laurie A, Doig S, Hargreaves E, Fraser AR, Turner ML, Campbell JDM, McGowan NWA, Barry J, Moore JK, Hayes PC, Leeming DJ, Nielsen MJ, Musa K, Fallowfield JA, Forbes SJ.

Nat Med. 2019 Oct 7. doi: 10.1038/s41591-019-0599-8. [Epub ahead of print]

PMID:
31591593
4.

Achieving Appropriate Model Transparency: Challenges and Potential Solutions for Making Value-Based Decisions in the United States.

Carlson JJ, Walton SM, Basu A, Chapman RH, Campbell JD, McQueen RB, Pearson SD, Touchette DR, Veenstra D, Whittington MD, Ollendorf DA.

Pharmacoeconomics. 2019 Sep 5. doi: 10.1007/s40273-019-00832-2. [Epub ahead of print]

PMID:
31485925
5.

Exposure to the antimicrobial peptide LL-37 produces dendritic cells optimized for immunotherapy.

Findlay EG, Currie AJ, Zhang A, Ovciarikova J, Young L, Stevens H, McHugh BJ, Canel M, Gray M, Milling SWF, Campbell JDM, Savill J, Serrels A, Davidson DJ.

Oncoimmunology. 2019 May 1;8(8):1608106. doi: 10.1080/2162402X.2019.1608106. eCollection 2019.

6.

Predictors of Patient-Reported Outcomes at 2 Years After Revision Anterior Cruciate Ligament Reconstruction.

MARS Group, Wright RW, Huston LJ, Haas AK, Allen CR, Anderson AF, Cooper DE, DeBerardino TM, Dunn WR, Lantz BBA, Mann B, Spindler KP, Stuart MJ, Nwosu SK, Albright JP, Amendola AN, Andrish JT, Annunziata CC, Arciero RA, Bach BR Jr, Baker CL 3rd, Bartolozzi AR, Baumgarten KM, Bechler JR, Berg JH, Bernas GA, Brockmeier SF, Brophy RH, Bush-Joseph CA, Brad Butler V J, Campbell JD, Carey JL, Carpenter JE, Cole BJ, Cooper JM, Cox CL, Creighton RA, Dahm DL, David TS, Flanigan DC, Frederick RW, Ganley TJ, Garofoli EA, Gatt CJ Jr, Gecha SR, Giffin JR, Hame SL, Hannafin JA, Harner CD, Harris NL Jr, Hechtman KS, Hershman EB, Hoellrich RG, Hosea TM, Johnson DC, Johnson TS, Jones MH, Kaeding CC, Kamath GV, Klootwyk TE, Levy BA, Ma CB, Maiers GP 2nd, Marx RG, Matava MJ, Mathien GM, McAllister DR, McCarty EC, McCormack RG, Miller BS, Nissen CW, O'Neill DF, Owens BD, Parker RD, Purnell ML, Ramappa AJ, Rauh MA, Rettig AC, Sekiya JK, Shea KG, Sherman OH, Slauterbeck JR, Smith MV, Spang JT, Svoboda LSJ, Taft TN, Tenuta JJ, Tingstad EM, Vidal AF, Viskontas DG, White RA, Williams JS Jr, Wolcott ML, Wolf BR, York JJ.

Am J Sports Med. 2019 Aug;47(10):2394-2401. doi: 10.1177/0363546519862279. Epub 2019 Jul 18.

PMID:
31318611
7.

Pipeliner: A Nextflow-Based Framework for the Definition of Sequencing Data Processing Pipelines.

Federico A, Karagiannis T, Karri K, Kishore D, Koga Y, Campbell JD, Monti S.

Front Genet. 2019 Jun 28;10:614. doi: 10.3389/fgene.2019.00614. eCollection 2019.

8.

Indications for Penile Prosthesis Revision: Lessons Learned to Limit Technical Causes of Reoperation.

Chan EP, Punjani N, Campbell JD, Abed H, Brock G.

J Sex Med. 2019 Sep;16(9):1444-1450. doi: 10.1016/j.jsxm.2019.06.003. Epub 2019 Jul 11.

PMID:
31303570
9.

EDITORIAL COMMENT.

Campbell JD, Brock GB.

Urology. 2019 Jul;129:117. doi: 10.1016/j.urology.2019.01.056. No abstract available.

PMID:
31234993
10.

Relationship Between Sports Participation After Revision Anterior Cruciate Ligament Reconstruction and 2-Year Patient-Reported Outcome Measures.

MARS Group, Bigouette JP, Owen EC, Lantz BBA, Hoellrich RG, Huston LJ, Haas AK, Allen CR, Anderson AF, Cooper DE, DeBerardino TM, Dunn WR, Mann B, Spindler KP, Stuart MJ, Wright RW, Albright JP, Amendola AN, Andrish JT, Annunziata CC, Arciero RA, Bach BR Jr, Baker CL 3rd, Bartolozzi AR, Baumgarten KM, Bechler JR, Berg JH, Bernas GA, Brockmeier SF, Brophy RH, Bush-Joseph CA, Butler JB, Campbell JD, Carey JL, Carpenter JE, Cole BJ, Cooper JM, Cox CL, Creighton RA, Dahm DL, David TS, Flanigan DC, Frederick RW, Ganley TJ, Garofoli EA, Gatt CJ Jr, Gecha SR, Giffin JR, Hame SL, Hannafin JA, Harner CD, Harris NL Jr, Hechtman KS, Hershman EB, Hosea TM, Johnson DC, Johnson TS, Jones MH, Kaeding CC, Kamath GV, Klootwyk TE, Levy BA, Ma CB, Maiers GP 2nd, Marx RG, Matava MJ, Mathien GM, McAllister DR, McCarty EC, McCormack RG, Miller BS, Nissen CW, O'Neill DF, Owens BD, Parker RD, Purnell ML, Ramappa AJ, Rauh MA, Rettig AC, Sekiya JK, Shea KG, Sherman OH, Slauterbeck JR, Smith MV, Spang JT, Svoboda SJ LTC, Taft TN, Tenuta JJ, Tingstad EM, Vidal AF, Viskontas DG, White RA, Williams JS Jr, Wolcott ML, Wolf BR, York JJ.

Am J Sports Med. 2019 Jul;47(9):2056-2066. doi: 10.1177/0363546519856348. Epub 2019 Jun 21.

PMID:
31225999
11.

Paying for CAR-T Therapy Amidst Limited Health System Resources.

Campbell JD, Whittington MD.

J Clin Oncol. 2019 Aug 20;37(24):2095-2097. doi: 10.1200/JCO.19.01113. Epub 2019 Jun 3. No abstract available.

PMID:
31157580
12.

The promise of Immuno-oncology: implications for defining the value of cancer treatment.

Kaufman HL, Atkins MB, Subedi P, Wu J, Chambers J, Joseph Mattingly T 2nd, Campbell JD, Allen J, Ferris AE, Schilsky RL, Danielson D, Lichtenfeld JL, House L, Selig WKD.

J Immunother Cancer. 2019 May 17;7(1):129. doi: 10.1186/s40425-019-0594-0.

13.

scruff: an R/Bioconductor package for preprocessing single-cell RNA-sequencing data.

Wang Z, Hu J, Johnson WE, Campbell JD.

BMC Bioinformatics. 2019 May 2;20(1):222. doi: 10.1186/s12859-019-2797-2.

14.

Comment on "Cost-Effectiveness of Niraparib Versus Routine Surveillance, Olaparib and Rucaparib for the Maintenance Treatment of Patients with Ovarian Cancer in the United States".

McQueen RB, Whittington MD, Chapman RH, Kumar VM, Campbell JD.

Pharmacoeconomics. 2019 Jul;37(7):963-964. doi: 10.1007/s40273-019-00802-8. No abstract available.

PMID:
31044348
15.

The Effectiveness and Value of Biologic Therapies for the Treatment of Uncontrolled Asthma.

Tice JA, Campbell JD, Synnott PG, Walsh JME, Kumar VM, Whittington M, Adair E, Rind D, Pearson SD.

J Manag Care Spec Pharm. 2019 May;25(5):510-514. doi: 10.18553/jmcp.2019.25.5.510.

16.

Molecular subtyping reveals immune alterations associated with progression of bronchial premalignant lesions.

Beane JE, Mazzilli SA, Campbell JD, Duclos G, Krysan K, Moy C, Perdomo C, Schaffer M, Liu G, Zhang S, Liu H, Vick J, Dhillon SS, Platero SJ, Dubinett SM, Stevenson C, Reid ME, Lenburg ME, Spira AE.

Nat Commun. 2019 Apr 23;10(1):1856. doi: 10.1038/s41467-019-09834-2.

17.

1,25-Dihydroxyvitamin D3 Restrains CD4+ T Cell Priming Ability of CD11c+ Dendritic Cells by Upregulating Expression of CD31.

Saul L, Mair I, Ivens A, Brown P, Samuel K, Campbell JDM, Soong DY, Kamenjarin N, Mellanby RJ.

Front Immunol. 2019 Mar 28;10:600. doi: 10.3389/fimmu.2019.00600. eCollection 2019.

18.

The REal Life EVidence AssessmeNt Tool (RELEVANT): development of a novel quality assurance asset to rate observational comparative effectiveness research studies.

Campbell JD, Perry R, Papadopoulos NG, Krishnan J, Brusselle G, Chisholm A, Bjermer L, Thomas M, van Ganse E, van den Berge M, Quint J, Price D, Roche N.

Clin Transl Allergy. 2019 Mar 27;9:21. doi: 10.1186/s13601-019-0256-9. eCollection 2019.

19.

Quality standards in respiratory real-life effectiveness research: the REal Life EVidence AssessmeNt Tool (RELEVANT): report from the Respiratory Effectiveness Group-European Academy of Allergy and Clinical Immunology Task Force.

Roche N, Campbell JD, Krishnan JA, Brusselle G, Chisholm A, Bjermer L, Thomas M, van Ganse E, van den Berge M, Christoff G, Quint J, Papadopoulos NG, Price D.

Clin Transl Allergy. 2019 Mar 27;9:20. doi: 10.1186/s13601-019-0255-x. eCollection 2019.

20.

Meta-analysis of randomized controlled trials that assess the efficacy of low-intensity shockwave therapy for the treatment of erectile dysfunction.

Campbell JD, Trock BJ, Oppenheim AR, Anusionwu I, Gor RA, Burnett AL.

Ther Adv Urol. 2019 Mar 29;11:1756287219838364. doi: 10.1177/1756287219838364. eCollection 2019 Jan-Dec.

21.

Is Prevalence of Atherosclerotic Risk Factors Increasing Among Young Adults? It Depends on How You Ask.

Leppert MH, Poisson SN, Sillau SH, Campbell JD, Ho PM, Burke JF.

J Am Heart Assoc. 2019 Mar 19;8(6):e010883. doi: 10.1161/JAHA.118.010883.

22.

Long-term Survival and Cost-effectiveness Associated With Axicabtagene Ciloleucel vs Chemotherapy for Treatment of B-Cell Lymphoma.

Whittington MD, McQueen RB, Ollendorf DA, Kumar VM, Chapman RH, Tice JA, Pearson SD, Campbell JD.

JAMA Netw Open. 2019 Feb 1;2(2):e190035. doi: 10.1001/jamanetworkopen.2019.0035.

23.

Long-term follow up after third-party viral-specific cytotoxic lymphocytes for immunosuppression- and Epstein-Barr virus-associated lymphoproliferative disease.

Kazi S, Mathur A, Wilkie G, Cheal K, Battle R, McGowan N, Fraser N, Hargreaves E, Turner D, Campbell JDM, Turner M, Vickers MA.

Haematologica. 2019 Aug;104(8):e356-e359. doi: 10.3324/haematol.2018.207548. Epub 2019 Feb 21. No abstract available.

24.

Validation of an algorithm for identifying MS cases in administrative health claims datasets.

Culpepper WJ, Marrie RA, Langer-Gould A, Wallin MT, Campbell JD, Nelson LM, Kaye WE, Wagner L, Tremlett H, Chen LH, Leung S, Evans C, Yao S, LaRocca NG; United States Multiple Sclerosis Prevalence Workgroup (MSPWG).

Neurology. 2019 Mar 5;92(10):e1016-e1028. doi: 10.1212/WNL.0000000000007043. Epub 2019 Feb 15.

25.

The prevalence of MS in the United States: A population-based estimate using health claims data.

Wallin MT, Culpepper WJ, Campbell JD, Nelson LM, Langer-Gould A, Marrie RA, Cutter GR, Kaye WE, Wagner L, Tremlett H, Buka SL, Dilokthornsakul P, Topol B, Chen LH, LaRocca NG; US Multiple Sclerosis Prevalence Workgroup.

Neurology. 2019 Mar 5;92(10):e1029-e1040. doi: 10.1212/WNL.0000000000007035. Epub 2019 Feb 15. Erratum in: Neurology. 2019 Oct 8;93(15):688.

26.

Comparison of weighting methods used in multicriteria decision analysis frameworks in healthcare with focus on low- and middle-income countries.

Németh B, Molnár A, Bozóki S, Wijaya K, Inotai A, Campbell JD, Kaló Z.

J Comp Eff Res. 2019 Mar;8(4):195-204. doi: 10.2217/cer-2018-0102. Epub 2019 Feb 15.

27.

Allogeneic Ex Vivo Expanded Corneal Epithelial Stem Cell Transplantation: A Randomized Controlled Clinical Trial.

Campbell JDM, Ahmad S, Agrawal A, Bienek C, Atkinson A, Mcgowan NWA, Kaye S, Mantry S, Ramaesh K, Glover A, Pelly J, MacRury C, MacDonald M, Hargreaves E, Barry J, Drain J, Cuthbertson B, Nerurkar L, Downing I, Fraser AR, Turner ML, Dhillon B.

Stem Cells Transl Med. 2019 Apr;8(4):323-331. doi: 10.1002/sctm.18-0140. Epub 2019 Jan 28.

28.

Hydro-Jet Dissection of the Cavernous Nerves Preserves Erection Function in a Radical Prostatectomy Animal Model.

Campbell JD, Alenezi H, DeYoung LX, Brock GB, Pautler SE.

Sex Med. 2019 Mar;7(1):104-110. doi: 10.1016/j.esxm.2018.11.006. Epub 2019 Jan 21.

29.

Ten quick tips for sharing open genomic data.

Brown AV, Campbell JD, Assefa T, Grant D, Nelson RT, Weeks NT, Cannon SB.

PLoS Comput Biol. 2018 Dec 27;14(12):e1006472. doi: 10.1371/journal.pcbi.1006472. eCollection 2018 Dec.

30.

Assessing the Value of Sarilumab Monotherapy for Adults with Moderately to Severely Active Rheumatoid Arthritis: A Cost-Effectiveness Analysis.

Whittington MD, McQueen RB, Ollendorf DA, Chapman RH, Kumar VM, Synnott PG, Agboola F, Campbell JD.

J Manag Care Spec Pharm. 2019 Jan;25(1):80-87. doi: 10.18553/jmcp.2019.25.1.080. Erratum in: J Manag Care Spec Pharm. 2019 Jun;25(6):726.

31.

Preclinical development of the TLR9 agonist DV281 as an inhaled aerosolized immunotherapeutic for lung cancer: Pharmacological profile in mice, non-human primates, and human primary cells.

Kell SA, Kachura MA, Renn A, Traquina P, Coffman RL, Campbell JD.

Int Immunopharmacol. 2019 Jan;66:296-308. doi: 10.1016/j.intimp.2018.11.019. Epub 2018 Nov 29.

PMID:
30502651
32.

Accounting for All Costs in the Total Cost of Chimeric Antigen Receptor T-Cell Immunotherapy.

Whittington MD, Ollendorf DA, Campbell JD.

JAMA Oncol. 2018 Dec 1;4(12):1784-1785. doi: 10.1001/jamaoncol.2018.4625. No abstract available.

PMID:
30325984
33.

Long-term Survival and Value of Chimeric Antigen Receptor T-Cell Therapy for Pediatric Patients With Relapsed or Refractory Leukemia.

Whittington MD, McQueen RB, Ollendorf DA, Kumar VM, Chapman RH, Tice JA, Pearson SD, Campbell JD.

JAMA Pediatr. 2018 Dec 1;172(12):1161-1168. doi: 10.1001/jamapediatrics.2018.2530.

34.

Flow cytometric assays for identity, safety and potency of cellular therapies.

Campbell JDM, Fraser AR.

Cytometry B Clin Cytom. 2018 Sep;94(5):569-579. doi: 10.1002/cyto.b.21735. Review.

35.

Fair global drug pricing.

Campbell JD, Kaló Z.

Expert Rev Pharmacoecon Outcomes Res. 2018 Dec;18(6):581-583. doi: 10.1080/14737167.2018.1524296. Epub 2018 Sep 28. No abstract available.

PMID:
30215535
36.

Update From the Advisory Committee on Immunization Practices.

O'Leary ST, Campbell JD, Kimberlin DW.

J Pediatric Infect Dis Soc. 2018 Dec 3;7(4):270-274. doi: 10.1093/jpids/piy070.

PMID:
30113691
37.

Guidance toward the implementation of multicriteria decision analysis framework in developing countries.

Inotai A, Nguyen HT, Hidayat B, Nurgozhin T, Kiet PHT, Campbell JD, Németh B, Maniadakis N, Brixner D, Wijaya K, Kaló Z.

Expert Rev Pharmacoecon Outcomes Res. 2018 Dec;18(6):585-592. doi: 10.1080/14737167.2018.1508345. Epub 2018 Aug 24.

PMID:
30092151
38.

Prices For Common Cardiovascular Drugs In The US Are Not Consistently Aligned With Value.

Campbell JD, Belozeroff V, Whittington MD, Rubin RJ, Raggi P, Briggs AH.

Health Aff (Millwood). 2018 Aug;37(8):1298-1305. doi: 10.1377/hlthaff.2018.0221.

PMID:
30080450
39.

Treatment patterns and related clinical consequences in adults with asthma.

Dilokthornsakul P, Thompson AM, Campbell JD.

J Asthma. 2019 Jul;56(7):739-747. doi: 10.1080/02770903.2018.1490749. Epub 2018 Aug 24.

PMID:
29972095
40.

Physiologic Preoperative Knee Hyperextension Is a Predictor of Failure in an Anterior Cruciate Ligament Revision Cohort: A Report From the MARS Group.

MARS Group, Cooper DE, Dunn WR, Huston LJ, Haas AK, Spindler KP, Allen CR, Anderson AF, DeBerardino TM, Lantz BBA, Mann B, Stuart MJ, Albright JP, Amendola AN, Andrish JT, Annunziata CC, Arciero RA, Bach BR Jr, Baker CL 3rd, Bartolozzi AR, Baumgarten KM, Bechler JR, Berg JH, Bernas GA, Brockmeier SF, Brophy RH, Bush-Joseph CA, Butler V JB, Campbell JD, Carey JL, Carpenter JE, Cole BJ, Cooper JM, Cox CL, Creighton RA, Dahm DL, David TS, Flanigan DC, Frederick RW, Ganley TJ, Garofoli EA, Gatt CJ Jr, Gecha SR, Giffin JR, Hame SL, Hannafin JA, Harner CD, Harris NL Jr, Hechtman KS, Hershman EB, Hoellrich RG, Hosea TM, Johnson DC, Johnson TS, Jones MH, Kaeding CC, Kamath GV, Klootwyk TE, Levy BA, Ma CB, Maiers GP 2nd, Marx RG, Matava MJ, Mathien GM, McAllister DR, McCarty EC, McCormack RG, Miller BS, Nissen CW, O'Neill DF, Owens BD, Parker RD, Purnell ML, Ramappa AJ, Rauh MA, Rettig AC, Sekiya JK, Shea KG, Sherman OH, Slauterbeck JR, Smith MV, Spang JT, Svoboda SJ, Taft TN, Tenuta JJ, Tingstad EM, Vidal AF, Viskontas DG, White RA, Williams JS Jr, Wolcott ML, Wolf BR, York JJ, Wright RW.

Am J Sports Med. 2018 Oct;46(12):2836-2841. doi: 10.1177/0363546518777732. Epub 2018 Jun 8.

41.

Cost-Effectiveness of Biological Asthma Treatments: A Systematic Review and Recommendations for Future Economic Evaluations.

McQueen RB, Sheehan DN, Whittington MD, van Boven JFM, Campbell JD.

Pharmacoeconomics. 2018 Aug;36(8):957-971. doi: 10.1007/s40273-018-0658-x.

PMID:
29736895
42.

Cost-Effectiveness of Patent Foramen Ovale Closure Versus Medical Therapy for Secondary Stroke Prevention.

Leppert MH, Poisson SN, Carroll JD, Thaler DE, Kim CH, Orjuela KD, Ho PM, Burke JF, Campbell JD.

Stroke. 2018 Jun;49(6):1443-1450. doi: 10.1161/STROKEAHA.117.020322. Epub 2018 May 2.

43.

Achieving high value care for all and the perverse incentives of 340B price agreements.

Whittington MD, Campbell JD, McQueen RB.

Neurol Clin Pract. 2018 Apr;8(2):148-152. doi: 10.1212/CPJ.0000000000000437.

44.

Economic Value of Improved Accuracy for Self-Monitoring of Blood Glucose Devices for Type 1 and Type 2 Diabetes in England.

McQueen RB, Breton MD, Craig J, Holmes H, Whittington MD, Ott MA, Campbell JD.

J Diabetes Sci Technol. 2018 Sep;12(5):992-1001. doi: 10.1177/1932296818769098. Epub 2018 Apr 21.

45.

Shifting the Paradigm of Testosterone Replacement Therapy in Prostate Cancer.

Bell MA, Campbell JD, Joice G, Sopko NA, Burnett AL.

World J Mens Health. 2018 May;36(2):103-109. doi: 10.5534/wjmh.170007. Epub 2018 Mar 22. Review.

46.

Genomic, Pathway Network, and Immunologic Features Distinguishing Squamous Carcinomas.

Campbell JD, Yau C, Bowlby R, Liu Y, Brennan K, Fan H, Taylor AM, Wang C, Walter V, Akbani R, Byers LA, Creighton CJ, Coarfa C, Shih J, Cherniack AD, Gevaert O, Prunello M, Shen H, Anur P, Chen J, Cheng H, Hayes DN, Bullman S, Pedamallu CS, Ojesina AI, Sadeghi S, Mungall KL, Robertson AG, Benz C, Schultz A, Kanchi RS, Gay CM, Hegde A, Diao L, Wang J, Ma W, Sumazin P, Chiu HS, Chen TW, Gunaratne P, Donehower L, Rader JS, Zuna R, Al-Ahmadie H, Lazar AJ, Flores ER, Tsai KY, Zhou JH, Rustgi AK, Drill E, Shen R, Wong CK; Cancer Genome Atlas Research Network, Stuart JM, Laird PW, Hoadley KA, Weinstein JN, Peto M, Pickering CR, Chen Z, Van Waes C.

Cell Rep. 2018 Apr 3;23(1):194-212.e6. doi: 10.1016/j.celrep.2018.03.063.

47.

A Call for Open-Source Cost-Effectiveness Analysis.

McQueen RB, Padula WV, Campbell JD.

Ann Intern Med. 2018 Apr 3;168(7):528-529. doi: 10.7326/L17-0694. No abstract available.

PMID:
29610902
48.

Considerations for Cost-effectiveness Analysis of Curative Pediatric Therapies.

Whittington MD, McQueen RB, Campbell JD.

JAMA Pediatr. 2018 May 1;172(5):409-410. doi: 10.1001/jamapediatrics.2018.0049. No abstract available.

PMID:
29554182
49.

Voriconazole: Poor Oral Bioavailability and Possible Renal Toxicity in an Infant With Invasive Aspergillosis.

Walldorf JA, Kishk OA, Campbell JD, Lardieri AB.

J Pediatr Pharmacol Ther. 2018 Jan-Feb;23(1):54-58. doi: 10.5863/1551-6776-23.1.54.

50.

Assessing the impact of caring for a child with Dravet syndrome: Results of a caregiver survey.

Campbell JD, Whittington MD, Kim CH, VanderVeen GR, Knupp KG, Gammaitoni A.

Epilepsy Behav. 2018 Mar;80:152-156. doi: 10.1016/j.yebeh.2018.01.003. Epub 2018 Feb 2.

Supplemental Content

Loading ...
Support Center